NP / PA
Aspirus Stanley Hospital & Clinics, INC
Aspirus Stanley Hospital & Clinics, INC was paid $4.81M by Medicaid between Jan 2018 and Dec 2024, across 80 billing codes. Its largest line is 99284, emergency room visit (serious) — 12% of everything it billed.
33Billing provider infoASPIRUS STANLEY HOSPITAL & CLINICS, INC
STANLEY, WI 54768
STANLEY, WI 54768
33aNPI1053391730assigned 01/19/2006
33bProvider typeCertified Registered Nurse Anesthetist
28Total paid$4.81M
24GClaims77,126
24DCodes billed80
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Certified Registered Nurse Anesthetist providers in Wisconsin
Rank by total paid#2 of 15
Median peer was paid$5K
This provider vs. median930×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official YANG, JERRY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,690 | $541K | |
| 2019 | 10,570 | $698K | |
| 2020 | 8,921 | $609K | |
| 2021 | 11,526 | $636K | |
| 2022 | 11,311 | $711K | |
| 2023 | 11,698 | $718K | |
| 2024incomplete | 12,410 | $893K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 2,948 | 2,199 | $601K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 3,062 | 2,435 | $563K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 3,105 | 1,993 | $542K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 11% | 1,916 | 1,702 | $523K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.9% | 2,101 | 1,663 | $475K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.7% | 3,580 | 3,163 | $468K |
| 96361 | Intravenous infusion, hydration; each additional hour | 7.3% | 662 | 529 | $353K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 4.6% | 1,003 | 861 | $223K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 3.5% | 1,403 | 1,268 | $169K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.3% | 457 | 378 | $158K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.3% | 532 | 302 | $111K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.2% | 1,014 | 930 | $106K |
68 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.2% | 463 | $105K |
| 80053 | Comprehensive metabolic panel | <1% | 5,163 | $38K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,456 | $34K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,688 | $33K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,803 | $26K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 238 | $19K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,278 | $19K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,418 | $18K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 477 | $18K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 646 | $17K |
| 80061 | Lipid panel | <1% | 1,323 | $16K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 919 | $16K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 315 | $15K |
| 99001 | <1% | 1,811 | $13K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 29 | $13K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 817 | $12K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 967 | $11K |
| 84484 | <1% | 2,334 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 843 | $8K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 586 | $7K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 604 | $6K |
| 81001 | <1% | 2,493 | $5K | |
| 87802 | <1% | 369 | $5K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,597 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 803 | $5K |
| 83690 | <1% | 844 | $5K | |
| 87070 | <1% | 606 | $5K | |
| 85610 | <1% | 1,280 | $4K | |
| 83605 | <1% | 804 | $3K | |
| 83880 | <1% | 257 | $3K | |
| 87081 | <1% | 263 | $3K | |
| 80306 | <1% | 195 | $2K | |
| 83735 | <1% | 684 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,337 | $2K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 15 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,594 | $1K |
| 85379 | <1% | 219 | $978.83 | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,099 | $750.20 |
| 86140 | <1% | 214 | $727.68 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 76 | $653.96 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 15 | $583.23 |
| 81003 | <1% | 234 | $550.83 | |
| 87077 | <1% | 74 | $528.37 | |
| 85730 | <1% | 212 | $499.99 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 26 | $402.88 |
| 82805 | <1% | 15 | $359.99 | |
| 82150 | <1% | 81 | $338.43 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 14 | $324.05 |
| 81025 | <1% | 29 | $264.84 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 855 | $226.99 |
| 85027 | <1% | 45 | $196.86 | |
| 87420 | <1% | 16 | $191.81 | |
| 84153 | <1% | 12 | $143.02 | |
| 87088 | <1% | 32 | $142.12 | |
| 87040 | <1% | 22 | $63.96 | |
| 87186 | <1% | 14 | $63.48 | |
| 82550 | <1% | 35 | $54.97 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 806 | $29.08 |
| 94762 | <1% | 162 | $13.15 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 235 | $7.76 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 770 | $6.49 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 621 | $1.99 |
| A9270 | Non-covered item or service | <1% | 933 | $0.56 |
| J2704 | Injection, propofol, 10 mg | 0% | 68 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 26 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 32 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 15 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialYANG, JERRY (SVP & CHEIF FINANCIAL OFFICER)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.